How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?
Authors:
Open Access
- 30 November 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 32 (4) , 396-403
Abstract
Over 50% of ST-segment elevation myocardial infarction (STEMI) patients suffer multi-vessel coronary artery disease, which is known to be associated with worse prognosis. Treatment strategies used in clinical practice vary from acute multi-vessel percutaneous coronary intervention (PCI), through staged PCI procedures to a conservative approach with primary PCI of only the infarct-related artery (IRA) and subsequent medical therapy unless recurrent ischaemia occurs. Each approach has advantages and disadvantages. This review paper summarizes the international experience and authors’ opinion on this clinically important question. Multi-vessel disease in STEMI is not a single entity and thus the treatment approach should be individualized. However, the following general rules can be proposed till future large randomized trials prove otherwise: (i) Single-vessel acute PCI should be the default strategy (to treat only the IRA during the acute phase of STEMI). (ii) Acute multi-vessel PCI can be justified only in exceptional patients with multiple critical (>90%) and potentially unstable lesions. (iii) Significant lesions of the non-infarct arteries should be treated either medically or by staged revascularization procedures—both options are currently acceptable.Keywords
This publication has 38 references indexed in Scilit:
- Incidence, Predictors, and Outcome of New, Subsequent Lesions Treated With Percutaneous Coronary Intervention in Patients Presenting With Myocardial InfarctionThe American Journal of Cardiology, 2009
- Combined Impact of Age and Estimated Glomerular Filtration Rate on In-Hospital Mortality After Percutaneous Coronary Intervention for Acute Myocardial Infarction (from the American College of Cardiology National Cardiovascular Data Registry)The American Journal of Cardiology, 2009
- Management of acute myocardial infarction in patients presenting with persistent ST-segment elevationEuropean Heart Journal, 2008
- Culprit only versus complete coronary revascularization during primary PCIInternational Journal of Cardiology, 2008
- In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarctionThe American Journal of Cardiology, 2005
- Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarctionAmerican Heart Journal, 2004
- Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: A randomized comparisonAmerican Heart Journal, 2004
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsThe Lancet, 2003
- One-year follow-up results of “culprit” versus multivessel coronary angioplasty trialThe American Journal of Cardiology, 1993
- Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: Comparison of single-vessel versus multivessel coronary artery diseaseAmerican Heart Journal, 1992